» Articles » PMID: 27303363

Normocaloric Diet Restores Weight Gain and Insulin Sensitivity in Obese Mice

Abstract

An increased incidence of obesity is registered worldwide, and its association with insulin resistance and type 2 diabetes is closely related with increased morbidity and mortality for cardiovascular diseases. A major clinical problem in the management of obesity is the non-adherence or low adherence of patients to a hypocaloric dietetic restriction. In this study, we evaluated in obese mice the effects of shifting from high-calorie foods to normal diet on insulin sensitivity. Male C57BL/6JOlaHsd mice (n = 20) were fed with high fat diet (HFD) for a 24-week period. Afterward, body weight, energy, and food intake were measured in all animals, together with parameters of insulin sensitivity by homeostatic model assessment of insulin resistance and plasma glucose levels in response to insulin administration. Moreover, in half of these mice, Glut4 mRNA levels were measured in muscle at the end of the high fat treatment, whereas the rest of the animals (n = 10) were shifted to normocaloric diet (NCD) for 10 weeks, after which the same analyses were carried out. A significant reduction of body weight was found after the transition from high to normal fat diet, and this decrease correlated well with an improvement in insulin sensitivity. In fact, we found a reduction in serum insulin levels and the recovery of insulin responsiveness in terms of glucose disposal measured by insulin tolerance test and Glut4 mRNA and protein expression. These results indicate that obesity-related insulin resistance may be rescued by shifting from HFD to NCD.

Citing Articles

Assessing clenbuterol's modulation of metabolic and inflammatory pathways in Nile tilapia (Oreochromas niloticous) fed high fat diet.

Rashwan A, Assar D, Salah A, Abualreesh M, Salem S, Althobaiti N Sci Rep. 2025; 15(1):1581.

PMID: 39794453 PMC: 11724019. DOI: 10.1038/s41598-024-84814-1.


Sirtuins as Players in the Signal Transduction of Flavonoids.

Lombardo G, Russo C, Maugeri A, Navarra M Int J Mol Sci. 2024; 25(4).

PMID: 38396635 PMC: 10889095. DOI: 10.3390/ijms25041956.


Inflammation and Obesity: The Pharmacological Role of Flavonoids in the Zebrafish Model.

Russo C, Maugeri A, Musumeci L, De Sarro G, Cirmi S, Navarra M Int J Mol Sci. 2023; 24(3).

PMID: 36769222 PMC: 9917473. DOI: 10.3390/ijms24032899.


The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival.

Letizia Hribal M, Mancuso E, Arcidiacono G, Greco A, Musca D, Procopio T Int J Endocrinol. 2020; 2020:1027386.

PMID: 32411219 PMC: 7199632. DOI: 10.1155/2020/1027386.


Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases.

Mirabelli M, Chiefari E, Arcidiacono B, Corigliano D, Brunetti F, Maggisano V Nutrients. 2020; 12(4).

PMID: 32290535 PMC: 7230471. DOI: 10.3390/nu12041066.


References
1.
Wadden T, Fujioka K, Toubro S, Gantz I, Erondu N, Chen M . A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet. Obesity (Silver Spring). 2010; 18(12):2301-10. PMC: 5708144. DOI: 10.1038/oby.2010.67. View

2.
Chiefari E, Paonessa F, Iiritano S, Le Pera I, Palmieri D, Brunetti G . The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol. 2009; 7:24. PMC: 2698822. DOI: 10.1186/1741-7007-7-24. View

3.
Paolisso G, Gambardella A, Amato L, Tortoriello R, DAmore A, Varricchio M . Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia. 1995; 38(11):1295-9. DOI: 10.1007/BF00401761. View

4.
Donini L, Cuzzolaro M, Gnessi L, Lubrano C, Migliaccio S, Aversa A . Obesity treatment: results after 4 years of a Nutritional and Psycho-Physical Rehabilitation Program in an outpatient setting. Eat Weight Disord. 2014; 19(2):249-60. DOI: 10.1007/s40519-014-0107-6. View

5.
Basciani S, Costantini D, Contini S, Persichetti A, Watanabe M, Mariani S . Safety and efficacy of a multiphase dietetic protocol with meal replacements including a step with very low calorie diet. Endocrine. 2014; 48(3):863-70. DOI: 10.1007/s12020-014-0355-2. View